UA110170C2 - BCL-2 SELECTIVE AGENTS WHICH CAUSE APOPTOSIS FOR TREATMENT OF CANCER AND IMMUNE DISEASES - Google Patents
BCL-2 SELECTIVE AGENTS WHICH CAUSE APOPTOSIS FOR TREATMENT OF CANCER AND IMMUNE DISEASESInfo
- Publication number
- UA110170C2 UA110170C2 UAA201409941A UAA201409941A UA110170C2 UA 110170 C2 UA110170 C2 UA 110170C2 UA A201409941 A UAA201409941 A UA A201409941A UA A201409941 A UAA201409941 A UA A201409941A UA 110170 C2 UA110170 C2 UA 110170C2
- Authority
- UA
- Ukraine
- Prior art keywords
- bcl
- cancer
- treatment
- immune diseases
- selective agents
- Prior art date
Links
Abstract
Описані сполуки, які інгібують активність антиапоптотичних білків Bcl-2 і Bcl-xL, композиції, що містять дані сполуки, і способи лікування захворювань, у ході яких експресується антиапоптичний білок Bcl-2.Compounds that inhibit the activity of the anti-apoptotic proteins Bcl-2 and Bcl-xL, compositions containing these compounds, and methods for treating diseases in which the anti-apoptotic protein Bcl-2 is expressed are described.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12027508P | 2008-12-05 | 2008-12-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
UA110170C2 true UA110170C2 (en) | 2015-11-25 |
Family
ID=52989304
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA201108414A UA107655C2 (en) | 2008-12-05 | 2009-04-12 | SELECTIVE BCL-2 ANTIAPOPTIC PROTEIN INHIBITORS FOR TREATMENT OF CANCER AND IMMUNE DISEASES |
UAA201409941A UA110170C2 (en) | 2008-12-05 | 2009-12-04 | BCL-2 SELECTIVE AGENTS WHICH CAUSE APOPTOSIS FOR TREATMENT OF CANCER AND IMMUNE DISEASES |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA201108414A UA107655C2 (en) | 2008-12-05 | 2009-04-12 | SELECTIVE BCL-2 ANTIAPOPTIC PROTEIN INHIBITORS FOR TREATMENT OF CANCER AND IMMUNE DISEASES |
Country Status (1)
Country | Link |
---|---|
UA (2) | UA107655C2 (en) |
-
2009
- 2009-04-12 UA UAA201108414A patent/UA107655C2/en unknown
- 2009-12-04 UA UAA201409941A patent/UA110170C2/en unknown
Also Published As
Publication number | Publication date |
---|---|
UA107655C2 (en) | 2015-02-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UA108193C2 (en) | APOPTOZINDUCE FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTO-IMMUNE DISEASES | |
PH12018501264A1 (en) | Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases | |
UA107706C2 (en) | Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases | |
PH12015500297A1 (en) | Adoptosis-inducing agents for the treatment of cancer and immune and automoimmune disease | |
MY158932A (en) | Sulfonamide derivatives as bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases | |
UA106403C2 (en) | Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases | |
UA106640C2 (en) | Bcl-2-Selective Apoptosis Inducer for Cancer and Immune Diseases | |
NZ631701A (en) | Apoptosis-including agents for the treatment of cancer and immune and autoimmune diseases | |
MX2011007681A (en) | Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases. | |
SG10201406608YA (en) | Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases | |
UA112326C2 (en) | APOPTOSIS CAUSES FOR TREATMENT OF Malignant Neoplasms And Immune And Autoimmune Diseases | |
UA110170C2 (en) | BCL-2 SELECTIVE AGENTS WHICH CAUSE APOPTOSIS FOR TREATMENT OF CANCER AND IMMUNE DISEASES |